Related Experiment Video
Updated: Sep 18, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Raising venture capital in the biopharma industry
1Generation Capital, LLC, c/o VAI, 1190 Bordeaux Drive, Sunnyvale, CA 94089, USA. levl@generation-capital.com
Abstract:
Raising venture capital (VC) is both an art and a science. Future entrepreneurs should carefully consider the various issues of VC financing that have a strong impact on the success of their business. In addition to attracting the best venture capital firms, these issues include such subtle but important points as the timing of financing (especially of the first round), external support sources, desirable qualities of a VC firm, amount to be raised, establishing a productive interface between the founders and the venture capitalists, and most importantly the effects of well-executed VC funding on hiring senior executives and scientific leaders.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Clinical Trials: Overview
Biopharmaceutics and Pharmacokinetics: Overview
Drug Discovery: Overview

